Morphology and prognostic value of tumor budding in rectal cancer after neoadjuvant radiotherapy

Human Pathology

Volumn 43, Issue 7, 2012, Pages 1061-1067

  Du, Changzheng ^a   Xue, Weicheng ^a   Li, Jiyou ^a   Cai, Yong ^a   Gu, Jin ^a  

^a PEKING UNIVERSITY CANCER HOSPITAL AND INSTITUTE   (China)

Author keywords

Neoadjuvant radiotherapy; Rectal cancer; Tumor budding

Indexed keywords

CARCINOEMBYRONIC ANTIGEN; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER INVASION; CANCER MORPHOLOGY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER SURGERY; DISEASE FREE SURVIVAL; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFLAMMATORY CELL; IRRADIATION; MAJOR CLINICAL STUDY; MALE; RECTUM CANCER; TREATMENT OUTCOME; TUMOR GROWTH; TUMOR REGRESSION;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROGNOSIS; RADIOTHERAPY, ADJUVANT; RECTAL NEOPLASMS;

EID: 84862508557     PISSN: 00468177     EISSN: 15328392     Source Type: Journal    
DOI: 10.1016/j.humpath.2011.07.026     Document Type: Article

References (31)

1. Meredith KL, Hoffe SE, Shibata D. The multidisciplinary management of rectal cancer. Surg Clin North Am 2009;89:177-215.
2. Sebag-Montefiore D, Bujko K, Valentini V. Rectal cancer multi-disciplinary management: evidences and future landscape. Radiother Oncol 2009;92:145-7.
3. Wille-Jorgensen P, Bulow S. The multidisciplinary team conference in rectal cancer-a step forward. Colorectal Dis 2009;11:231-2.
4. Ramsey S, Tepper JE. Rectal cancer radiotherapy. Cancer J 2007;13:204-9.
5. Valentini V, Aristei C, Glimelius B, et al. Multidisciplinary Rectal Cancer Management: 2nd European Rectal Cancer Consensus Conference (EURECA-CC2). Radiother Oncol 2009;92:148-63.
6. Moser L, Ritz JP, Hinkelbein W, Hocht S. Adjuvant and neoadjuvant chemoradiation or radiotherapy in rectal cancer - a review focusing on open questions. Int J Colorectal Dis 2008;23:227-36.
7. Jass JR, O'Brien MJ, Riddell RH, Snover DC. Recommendations for the reporting of surgically resected specimens of colorectal carcinoma. HUM PATHOL 2007;38:537-45.
8. Kuo LJ, Liu MC, Jian JJ, et al. Is final TNM staging a predictor for survival in locally advanced rectal cancer after preoperative chemoradiation therapy? Ann Surg Oncol 2007;14:2766-72.
9. Benzoni E, Intersimone D, Terrosu G, et al. Prognostic value of tumour regression grading and depth of neoplastic infiltration within the perirectal fat after combined neoadjuvant chemo-radiotherapy and surgery for rectal cancer. J Clin Pathol 2006;59:505-12.
10. Rodel C, Martus P, Papadoupolos T, et al. Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer. J Clin Oncol 2005;23:8688-96.
11. Shinto E, Jass JR, Tsuda H, et al. Differential prognostic significance of morphologic invasive markers in colorectal cancer: tumor budding and cytoplasmic podia. Dis Colon Rectum 2006;49:1422-30.
12. Hase K, Shatney C, Johnson D, et al. Prognostic value of tumor "budding" in patients with colorectal cancer. Dis Colon Rectum 1993;36:627-35.
13. Ueno H, Murphy J, Jass JR, et al. Tumour 'budding' as an index to estimate the potential of aggressiveness in rectal cancer. Histopathology 2002;40:127-32.
14. Sy J, Fung CL, Dent OF, et al. Tumor budding and survival after potentially curative resection of node-positive colon cancer. Dis Colon Rectum 2010;53:301-7.
15. Prall F. Tumour budding in colorectal carcinoma. Histopathology 2007;50:151-62.
16. Choi HJ, Park KJ, Shin JS, et al. Tumor budding as a prognostic marker in stage-III rectal carcinoma. Int J Colorectal Dis 2007;22:863-8.
17. Kanazawa H, Mitomi H, Nishiyama Y, et al. Tumour budding at invasive margins and outcome in colorectal cancer. Colorectal Dis 2008;10:41-7.
18. Masaki T, Matsuoka H, Sugiyama M, et al. Tumor budding and evidence-based treatment of T2 rectal carcinomas. J Surg Oncol 2005;92:59-63.
19. Turner RR, Li C, Compton CC. Newer pathologic assessment techniques for colorectal carcinoma. Clin Cancer Res 2007;13:6871s-6s.
20. Chinese Anti-Cancer Association. The surgical guideline of low rectal cancer. Chin J Gastrointest Surg 2005;8:88-90 [in Chinese].
21. Heald RJ, Husband EM, Ryall RD. The mesorectum in rectal cancer surgery - the clue to pelvic recurrence? Br J Surg 1982;69:613-6.
22. Ryan R, Gibbons D, Hyland JM, et al. Pathological response following long-course neoadjuvant chemoradiotherapy for locally advanced rectal cancer. Histopathology 2005;47:141-6.
23. Guzinska-Ustymowicz K, Zalewski B, Kasacka I, et al. Activity of cathepsin B and D in colorectal cancer: relationships with tumour budding. Anticancer Res 2004;24:2847-51.
24. Prall F, Ostwald C. High-degree tumor budding and podia-formation in sporadic colorectal carcinomas with K-ras gene mutations. HUM PATHOL 2007;38:1696-702.
25. Guzinska-Ustymowicz K. MMP-9 and cathepsin B expression in tumor budding as an indicator of a more aggressive phenotype of colorectal cancer (CRC). Anticancer Res 2006;26:1589-94.
26. Karamitopoulou E, Lugli A, Panayiotides I, et al. Systematic assessment of protein phenotypes characterizing high-grade tumour budding in mismatch repair-proficient colorectal cancer. Histopathology 2010;57:233-43.
27. Park KJ, Choi HJ, Roh MS, et al. Intensity of tumor budding and its prognostic implications in invasive colon carcinoma. Dis Colon Rectum 2005;48:1597-602.
28. Okuyama T, Oya M, Ishikawa H. Budding as a useful prognostic marker in pT3 well- or moderately-differentiated rectal adenocarcinoma. J Surg Oncol 2003;83:42-7.
29. Masaki T, Matsuoka H, Sugiyama M, et al. Budding as a useful determinant of the optimal treatment for T1 rectal carcinomas. Hepatogastroenterology 2003;50:388-91.
30. Dworak O, Keilholz L, Hoffmann A. Pathological features of rectal cancer after preoperative radiochemotherapy. Int J Colorectal Dis 1997;12:19-23.
31. Kim NK, Baik SH, Min BS, et al. A comparative study of volumetric analysis, histopathologic downstaging, and tumor regression grade in evaluating tumor response in locally advanced rectal cancer following preoperative chemoradiation. Int J Radiat Oncol Biol Phys 2007;67:204-10.